BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 33551988)

  • 21. Clinical features of Hispanic thyroid cancer cases and the role of known genetic variants on disease risk.
    Estrada-Florez AP; Bohórquez ME; Sahasrabudhe R; Prieto R; Lott P; Duque CS; Donado J; Mateus G; Bolaños F; Vélez A; Echeverry M; Carvajal-Carmona LG
    Medicine (Baltimore); 2016 Aug; 95(32):e4148. PubMed ID: 27512836
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Associations between rs965513/rs944289 and papillary thyroid carcinoma risk: a meta-analysis.
    Ai L; Liu X; Yao Y; Yu Y; Sun H; Yu Q
    Endocrine; 2014 Nov; 47(2):428-34. PubMed ID: 24723258
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effect of TP53 and P21 gene polymorphisms on papillary thyroid carcinoma susceptibility and clinical/pathological features.
    Heidari Z; Harati-Sadegh M; Arian A; Maruei-Milan R; Salimi S
    IUBMB Life; 2020 May; 72(5):922-930. PubMed ID: 31895498
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Single nucleotide polymorphisms of the Fas gene are associated with papillary thyroid cancer.
    Eun YG; Lee YC; Kim SK; Chung JH; Kwon KH; Park IS
    Auris Nasus Larynx; 2015 Aug; 42(4):326-31. PubMed ID: 25824544
    [TBL] [Abstract][Full Text] [Related]  

  • 25. rs965513 polymorphism as a common risk marker is associated with papillary thyroid cancer.
    Wang F; Yan D; Ji X; Han J; Chen M; Qiao H; Zhang S
    Oncotarget; 2016 Jul; 7(27):41336-41345. PubMed ID: 27191655
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Polymorphisms of the Highly Expressed IL-6 Gene in the Papillary Thyroid Cancer Susceptibility Among Chinese.
    Li H; Dai H; Li H; Li B; Shao Y
    Curr Mol Med; 2019; 19(6):443-451. PubMed ID: 31288714
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Novel genome-wide association study-based candidate loci for differentiated thyroid cancer risk.
    Figlioli G; Köhler A; Chen B; Elisei R; Romei C; Cipollini M; Cristaudo A; Bambi F; Paolicchi E; Hoffmann P; Herms S; Kalemba M; Kula D; Pastor S; Marcos R; Velázquez A; Jarząb B; Landi S; Hemminki K; Försti A; Gemignani F
    J Clin Endocrinol Metab; 2014 Oct; 99(10):E2084-92. PubMed ID: 25029422
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association between single nucleotide polymorphisms of upstream transcription factor 1 (USF1) and susceptibility to papillary thyroid cancer.
    Yuan Q; Bu Q; Li G; Zhang J; Cui T; Zhu R; Mu D
    Clin Endocrinol (Oxf); 2016 Apr; 84(4):564-70. PubMed ID: 26052935
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association of FOXE1 polyalanine repeat region with papillary thyroid cancer.
    Bullock M; Duncan EL; O'Neill C; Tacon L; Sywak M; Sidhu S; Delbridge L; Learoyd D; Robinson BG; Ludgate M; Clifton-Bligh RJ
    J Clin Endocrinol Metab; 2012 Sep; 97(9):E1814-9. PubMed ID: 22736773
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Targeted next-generation sequencing in papillary thyroid carcinoma patients looking for germline variants predisposing to the disease.
    Shen CT; Zhang GQ; Qiu ZL; Song HJ; Sun ZK; Luo QY
    Endocrine; 2019 Jun; 64(3):622-631. PubMed ID: 30826992
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effect of CASP3 rs4647610 and rs4647602 polymorphisms on tumour size and cancer stage in papillary thyroid carcinoma.
    Heidari Z; Eskandari M; Aryan A; Rostamzad F; Salimi S
    Br J Biomed Sci; 2020 Jul; 77(3):129-134. PubMed ID: 32151194
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Common genetic variants in the 8q24 region and risk of papillary thyroid cancer.
    Neta G; Yu CL; Brenner A; Gu F; Hutchinson A; Pfeiffer R; Sturgis EM; Xu L; Linet MS; Alexander BH; Chanock S; Sigurdson AJ
    Laryngoscope; 2012 May; 122(5):1040-2. PubMed ID: 22275265
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinicopathological significance of the single nucleotide polymorphism, rs2853669 within the TERT promoter in papillary thyroid carcinoma.
    Hirokawa T; Arimasu Y; Chiba T; Fujiwara M; Kamma H
    Pathol Int; 2020 Apr; 70(4):217-223. PubMed ID: 31943527
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association analysis between the interaction of RAS family genes mutations and papillary thyroid carcinoma in the Han Chinese population.
    Jin M; Li Z; Sun Y; Zhang M; Chen X; Zhao H; Yu Q
    Int J Med Sci; 2021; 18(2):441-447. PubMed ID: 33390813
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The FOXE1 locus is a major genetic determinant for radiation-related thyroid carcinoma in Chernobyl.
    Takahashi M; Saenko VA; Rogounovitch TI; Kawaguchi T; Drozd VM; Takigawa-Imamura H; Akulevich NM; Ratanajaraya C; Mitsutake N; Takamura N; Danilova LI; Lushchik ML; Demidchik YE; Heath S; Yamada R; Lathrop M; Matsuda F; Yamashita S
    Hum Mol Genet; 2010 Jun; 19(12):2516-23. PubMed ID: 20350937
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Common genetic variants in sex hormone pathway genes and papillary thyroid cancer risk.
    Schonfeld SJ; Neta G; Sturgis EM; Pfeiffer RM; Hutchinson AA; Xu L; Wheeler W; Guénel P; Rajaraman P; de Vathaire F; Ron E; Tucker MA; Chanock SJ; Sigurdson AJ; Brenner AV
    Thyroid; 2012 Feb; 22(2):151-6. PubMed ID: 22224819
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association between Genetic Polymorphisms in microRNA Machinery Genes and Risk of Papillary Thyroid Carcinoma.
    Mohammadpour-Gharehbagh A; Heidari Z; Eskandari M; Aryan A; Salimi S
    Pathol Oncol Res; 2020 Apr; 26(2):1235-1241. PubMed ID: 31250375
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Assessing thyroid cancer risk using polygenic risk scores.
    Liyanarachchi S; Gudmundsson J; Ferkingstad E; He H; Jonasson JG; Tragante V; Asselbergs FW; Xu L; Kiemeney LA; Netea-Maier RT; Mayordomo JI; Plantinga TS; Hjartarson H; Hrafnkelsson J; Sturgis EM; Brock P; Nabhan F; Thorleifsson G; Ringel MD; Stefansson K; de la Chapelle A
    Proc Natl Acad Sci U S A; 2020 Mar; 117(11):5997-6002. PubMed ID: 32132206
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Polymorphisms in selected DNA repair genes and cell cycle regulating genes involved in the risk of papillary thyroid carcinoma.
    Halkova T; Dvorakova S; Sykorova V; Vaclavikova E; Vcelak J; Vlcek P; Sykorova P; Kodetova D; Betka J; Lastuvka P; Bavor P; Hoch J; Katra R; Bendlova B
    Cancer Biomark; 2016 Jun; 17(1):97-106. PubMed ID: 27314298
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The investigation of foxe1 variations in papillary thyroid carcinoma.
    Somuncu E; Karatas A; Ferahman S; Saygili N; Yilmaz E; Ozturk O; Kapan M
    Int J Clin Exp Pathol; 2015; 8(10):13458-64. PubMed ID: 26722557
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.